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Abstract 
At present, there are no in vivo or in vitro methods developed which has been adopted by 
regulatory authorities to assess photosensitization induced by chemicals. Recently, we have 
proposed the use of THP-1 cells and IL-8 release to identify the potential of chemicals to 
induce skin sensitization. Based on the assumption that sensitization and photosensitization 
share common mechanisms, the aim of this work was to explore the THP-1 model as an in 
vitro model to identify photoallergenic chemicals.  
THP-1 cells were exposed to 7 photoallergens and 3 photoirritants and irradiated with UVA 
light or kept in dark. Non phototoxic allergens or irritants were also included as negative 
compounds. Following 24 h of incubation, cytotoxicity and IL-8 release were measured. At 
subtoxic concentrations, photoallergens produced a dose-related increase in IL-8 release 
after irradiation. Some photoirritants also produced a slight increase in IL-8 release. 
However, when the overall stimulation indexes of IL-8 were calculated for each chemical, six 
out of seven photoallergens tested reached a stimulation index above 2, while the entire set 
of negative compounds had stimulation indexes below 2. Our data suggest that this assay 
may become a useful cell-based in vitro test for evaluating the photosensitizing potential of 
chemicals. 
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1. Introduction 
Safety assessment of ingredients is an important part of the development of cosmetics and 
drugs. For certain medical and consumer products, photosafety testing has become a 
mandatory regulatory requirement. This may include an assessment of acute phototoxicity 
(photoirritation), photoallergy, photogenotoxicity and photocarcinogenicity (EMA, 2012). In 
this sense, differentiation between photoallergenic and phototoxic reactions induced by low 
molecular weight compounds represents a current problem. Historically, the toxicological 
evaluation is conducted on animals, however, the 7th Amendment to the Cosmetics 
Directive (Directive 76/ 768/EEC) aims for the complete replacement of animal testing by 
2013. Moreover, the new European Chemicals Legislation (REACH, EU, 2006) favours 
alternative methods, if validated and appropriate. Therefore, the development of innovative 
in vitro alternatives is needed to comply with the amendment and, in order to replace the 
currently used in vivo methods. 
 
The adverse cutaneous response to phototoxic compounds can be reproduced, in vitro, 
using human skin models. In this sense the 3T3 Neutral Red Uptake phototoxicity test has 
been adopted by OECD as Test Guideline 432 (OECD, 2004) as a general screen for the 
phototoxic potential of UV absorbing substances. However, the validated 3T3 NRU PT test 
has some limitations and may provide false positive results. For this reasons, the Photo RBC 
and the Human 3-D Skin Model In Vitro Phototoxicity test, are two additional assays 
regarded as useful and important adjunct test to overcome the limitations of the 3T3 NRU PT 
(Ceridono et al., 2012). 
 
The case of photosensitization and photoallergic reactions is different because there are no 
in vivo methods validated. Various laboratory animal study assays have been proposed, 
mainly methods that were originally developed for investigating contact allergy and were 
subsequently adapted for photoallergy, as the guinea-pig maximization test (Jordan, 1982; 
Magnuson et al., 1969; Maurer et al., 1980), the localized lymph node assay (Ulrich et al., 
2001), and the mouse ear swelling model (Gerberick and Ryan, 1990). Although, currently 
no standardized methodology has been agreed or adopted by regulatory authorities the 
Photo Local Lymph Nodule Assay protocol is the more promising in vivo to identify potential 
photoallergic from phototoxic compounds. The advantage of the Photo-LLNA is its ability to 
identify photoirritant and photoallergic compounds by calculation of the Differentiation Index 
(Neumann et al., 2005), which allow this assay to evaluate photoallergic properties of a 
supposed photoreactive agent. 
 
 
Although the exact mechanism of photoallergy is not completely known, it is considered to 
be a form of delayed type hypersensitivity, as contact dermatitis, which occurs when an 
exogenous agent (photoallergen) is applied to the skin and subsequently exposed to 
ultraviolet (UV) and/or visible radiation (Kerr and Ferguson, 2010). In the case of 
photoallergy, the hapten is a photosensitizer that requires light exposure for its activation 
(Pendlington and Barratt, 1990). The initial step in the induction of delayed type 
hypersensitivity is the uptake of the hapten by antigen-presenting cells within the epidermis. 
The next step implies the migration of such antigen-presenting cells to the lymph node 
where they stimulate the proliferation of antigen-specific T-lymphocytes (Gerberick et al., 
1991a; Gerberick et al., 1991b). Langerhans cells (LCs) are a type of dendritic cells (DCs), 
which are the main antigen-presenting cells present in the skin. During the induction phase 
of (photo-)sensitization, they differentiate and mature expressing co-stimulatory and 
adhesion molecules and secrete various cytokines, including IL-1beta and IL-8 (Banchereau 
et al., 2000). 
 
In the case of contact sensitization, DC and DC-like cells has been used to develop new in 
vitro methods to discriminate contact sensitizers from irritants including LCs (Krasteva et al., 
1996), human peripheral blood mono-nuclear cells (PBMC) (Coutant et al., 1999; Guironnet 
et al., 2000; Pichowski et al., 2000; Tuschl et al., 2000); CD34+ hematopoietic progenitor 
cells (HPC) (Boislève et al., 2004), and DC-like cell lines, such as THP-1 (Yoshida et al., 
2003), U937 (Python et al., 2007), KG-1 (Hulette et al., 2002), and MUTZ-3 (Azam et al., 
2006). Major drawbacks of DCs and peripheral blood derived DCs are their complex and 
expensive preparation procedures, sourcing issues and their donor-to-donor variability. In 
this sense, the use of DC-like cell lines is gaining much attention. Notably, two assays 
MUSST and h-CLAT based on U937 and THP-1 cell lines, respectively, are currently under 
pre-validation at ECVAM (Aeby et al., 2010).  
 
Regarding photosensitization only few works have been published mainly based on DC-like 
cells (Hoya et al., 2009; Karschuk et al., 2010), and more recently a promising keratinocyte 
photoassay has been proposed (Galbiati et al, 2013). But to date no in vitro accepted 
alternative is available to identify the photoallergenic potential of new chemicals, although it 
is expected that chemicals showing photoallergic properties, are likely to give positive 
reactions in the 3T3 NRU PT test (SCCS/1501/12). On the basis of the evaluation of the 
photosafety of chemicals in a testing strategy,more efforts should be devoted to develop a 
reliable in vitro method to evaluate the photosensitization potential of new chemicals and to 
discriminate between photoirritants and photosensitizers.  
 
Recently, we have proposed THP-1 and the release of the chemokine IL-8, along with p38 
MAPK activation as a model for screening sensitizers (Mitjans et al., 2008; Mitjans et al., 
2010). Based on the assumption that contact photosensitization has the same mechanistic 
of contact sensitization, the purpose of this work was to explore the suitability of this model 
to discriminate photosensitizers from photoirritants.  
 
2. Materials and methods 
2.1. Chemicals 
 
Phototoxic and non-phototoxic chemicals were selected based on the information provided 
by similar published studies and reported to cause allergic contact dermatitis as showed in 
Table 1. 
 
Chlorpromazine hydrochloride (CPZ, CAS no. 69-09-0) was chosen as known 
photoallergens and photoirritants. 6-methylcoumarin (6-MC, CAS no. 92-48-8), 
benzophenone (BZP, CAS no. 119-61-9), ketoprofen (KETO, CAS no. 22071-15-4), 
avobenzone (1-(4-methoxyphenyl)-3-(4-tertr-butylphenyl)1,3-propendione) (AVO, CAS no. 
70356-09-1), 4-aminobenzoic acid (PABA, CAS no. 150-13-0) and 2-ethylhexyl-4-
methoxycinnamate (OMC, CAS no. 5466-77-3) as known photoallergens. Ibuprofen (IBU, 
CAS no. 15687-27-1), retinoic acid (RET, CAS no. 302-79-4) and 8-methoxypsoralen (8-
MOP, CAS no. 298-81-7) as known photoirritants. 2-aminophenol (2-AP, CAS no. 95-55-6), 
nickel sulfate (NiSO4, CAS no. 10101-97-0), and diethylmaleate (DEM, CAS no. 141-05-9) 
as known allergens. Octanoic acid (OCT, CAS no. 124-07-2), and sodium dodecyl sulfate 
(SDS, CAS no. 151-21-3) were chosen as known irritants. All compounds were purchased 
from Sigma-Aldrich (Saint Louis, MO, USA). Stock solutions of chemicals were prepared in 
dimethylsulfoxide immediately before use. The final concentration of dimethylsulfoxide 
(DMSO) never exceeded 1%. 
 
2.2. Cell culture  
 
The human monocytic leukemia cell line THP-1 was cultured in RPMI 1640 medium 
supplemented with 10% (v/v) of heat inactivated FBS, 2 mM L-glutamine, 100 U/ml penicillin, 
100 µg/ml streptomycin and 50 μM 2-mercaptoethanol, and incubated at 37 ºC, 5% CO2. 
 
2.3. Chemical treatment 
 
THP-1 cells were seeded into 24-well plates at a density of 1 x 106 cell/ml. The final volume 
in each well was 500 μl, the medium used contained 5% FBS and 5 µl of different 
concentrations of the chemicals. Each concentration was tested in triplicate and untreated 
cells (controls) were exposed to 5 µl of the vehicle (DMSO). Two plates were prepared in 
parallel, one was kept in dark (non-irradiated) and the other was irradiated immediately after 
applying chemical treatments.  
 
2.4. Light exposure of THP-1 
 
The irradiation of the samples was carried out in a photostability UV chamber (58 x 34 x 28 
cm) equipped with three UVA lamps Actinic BL TL/TL-D/T5 (Philips®, 43 V, 352 nm, 15W). 
Lamp spectra (Figure 1) show that maximum irradiance is found in the range of UVA 
irradiation with a peak at 365 nm. Irradiance has been routinely measured through the plate 
lid before cell exposure with a photoradiometer Delta OHM provided with a UVA probe 
(HD2302 - Italy) to determine UV dose using the following equation: 
E (J/cm2) = t(s) x P (W/cm2) 
Where E stands for UV dose, t represents the time expressed in seconds and, finally, P is 
the lamp potency. Cells were irradiated with a dosing of 1.6-2.1 mW/cm2 to give a final 
exposure of 1, 2.5, and 5 J/cm2. 
 
2.5. Cytotoxicity measured by the MTT assay 
 
After irradiation cells were incubated 24h (irradiated and non-irradiated plates), then plates 
were centrifuged, supernatants were collected and kept at -80ºC for IL-8 measurement. 500 
μl of a MTT solution 0.75 mg/ml was then added to each well. Cells were incubated for 3 h at 
37 ºC, plates were then centrifuged, medium discarded and cells lysed in 250 μl/well of a 
mixture of HCl/isopropanol. 100 μl of the resulting solutions was transferred to a 96-well 
plate and the absorbance was read at 550 nm using a Bio-Rad 550 microplate reader. Cell 
viability was calculated as the percentage of tetrazolium salt reduction by viable cells on 
each sample against the untreated cells. Seventy five percent cell viability (CV75) was 
calculated for each chemical by linear regression analysis of data.  
 
2.5. IL-8 release measurement 
 
IL-8 release was assessed in cell free supernatants using a human ELISA kit from Immuno 
Tools (Germany). Results are expressed in pg/ml. Limit of detection of 15.6 pg/ml. 
 
2.6. Data analysis and statistics  
 
Results are expressed as mean ± standard error of at least three independent experiments. 
Statistical analyses were performed using one-way analysis of variance (ANOVA) to 
determine the differences between datasets, followed by Dunnett’s post-hoc test for multiple 
comparisons using the SPSS®  software (SPSS Inc., Chicago, IL, USA). p < 0.05 and p < 
0.01 were considered significant.  
 
Results 
 
3.1. Determination of the appropriate UVA dose 
 
Preliminary experiments were carried out in order to establish the appropriate UVA dose. 
The aim of those experiments was to find the UVA dose that does not cause cell cytotoxicity 
or a significant IL-8 release to cell supernatants on control cells (not treated with chemicals) 
but, at the same time, still provide enough energy to photoactivate the chemicals with 
photosensitization potential causing a significant response on THP-1 in terms of IL-8 
release. To perform this, untreated THP-1 cells were exposed to different UVA doses (1, 2.5 
and 5 J/cm2) and cell viability and IL-8 release was tested 24 h after light exposure. In 
parallel, chlorpromazine was selected as a reference compound to test the cell response 
under UVA conditions. THP-1 cells were treated with different concentrations of 
chlorpromazine and then were exposed to the different UVA doses. Results are shown in 
Figure 2. Based on this data, the dose of 2.5 J/cm2 was selected for further experiments, as 
it did not cause a decrease on cell viability or a significant release of IL-8 on control cells.  
This irradiation dose was enough to induce a significant release of IL-8 in presence of 
chlorpromazine, without a remarkable cell viability decrease.  
 
3.2. Effect of the selected chemicals on cell viability  
 
The concentration of the chemical resulting in 75% of cell viability (CV75) respect to vehicle 
treated cells 24 h after treatment was calculated for all chemicals in non-irradiated and 
irradiated (2.5 J/cm2) conditions. Results are presented in Table 2. Photoallergens and 
photoirritants showed photoreactivity as it is appreciated in the differences between CV75 
values between non-irradiated and irradiated cells. With the exception of 4-aminobenzoic 
acid and ibuprofen which did not show any cytotoxicity nor phototoxicity in our experimental 
conditions.  
 
3.3. Effect of light and the selected chemicals on IL-8 release 
 
The selection of the concentration range of each chemical was based on the cytotoxicity of 
the compounds. The use of a sub-toxic concentration of a sensitizer shows to be a key factor 
for the prediction of sensitization in THP-1 (Ashikaga et al., 2006; Yoshida et al., 2003). For 
this reason, we selected the CV75 of each chemical in irradiated conditions as the highest 
concentration tested and serial dilutions of this concentration were also tested. Results 
obtained with the selected chemicals are shown in Figures 3 and 4, where the release of IL-
8 is represented for irradiated and non-irradiated cells.  
 
The selected photosensitizing chemicals produced a dose-related increase in IL-8 release 
only under irradiation conditions, with the exception of AVO and OMC which produced a 
dose-related increase also without irradiation. The strongest responses were observed with 
CPZ, 6-MC, BZP and AVO, while KETO, PABA and OMC produced a moderate increase in 
IL-8 release. The photoirritant 8-MOP failed in producing an increase in IL-8 release, while 
the photoirritants RET and IBU produced a slight increase. In the case of allergens, NiSO4, 
2-AP and DEM, the dose-related increase appeared in both irradiated and non-irradiated 
cells. The irritants OCT and SDS failed to produce a significant IL-8 release under the same 
experimental conditions. 
 
In order to establish the suitability of the method to discriminate between photoallergens and 
negative compounds (photoirritants, allergens, and irritants), stimulation indexes (SI) were 
calculated for irradiated (I-SI) and non-irradiated cells (NI-SI) as the ratio of IL-8 release of 
treated cells against untreated cells. An overall stimulation index (I-SI/NI-SI) was also 
calculated as the ratio of the stimulation indexes in irradiated and non-irradiated cells. Those 
stimulation indexes were represented in Figure 5, with a single concentration for each 
compound in which cell viability was above the 75%.  
 
Photoallergens showed SI in irradiated conditions that varied between almost 2 to 16, 
depending on the concentration assayed, while in non-irradiated conditions it could not be 
detected any stimulation in IL-8 release, with the abovementioned exceptions, AVO and 
OMC, which SIs in non-irradiated conditions reached almost 5 and 9 times-folds, 
respectively. In contrast, in most cases the negative compounds tested (photoirritants, 
allergens and irritants) exhibited SI in irradiated conditions below 2, with the exceptions of 
IBU and DEM but they did not exceed the 2.5 times-fold increase.  
 
When the overall SI was calculated, the results were similar to SI in irradiated cells with 
values between 2 and 17. The exception of OMC persisted with an overall SI of 0.9 mainly 
due to its high stimulation of IL-8 release on non-irradiated cells. The case of AVO was 
different to OMC because the SI of irradiated cells was higher than SI of non-irradiated cells; 
therefore, it exhibited an overall SI of 2.8. 
 
Discussion  
 
When drugs and chemicals are sold within the marketplace, it is clearly important to know in 
advance whether a molecule has the potential for photoallergy or not. A missed (photo-) 
allergen hinders the opportunity of preventive avoidance. Regulatory authorities have 
historically sought to have clinically relevant predictive information available before chemical 
approval. The in vitro 3T3 NRU PT is currently accepted as a valid screening in vitro method 
to assess phototoxic potential for soluble compounds (OECD, 2004; EMA, 2012). When a 
potential phototoxic compound is identified using this in vitro assay, a photoallergy 
assessment is generally warranted. However, nor animal-based or in vitro method has been 
accepted for evaluating photosensitization. And over the years, there has been considerable 
variation in the methodology used for photopatch testing in humans (Kerr and Ferguson, 
2010), making even more difficult to predict the photosensitizing potential of a particular 
chemical. 
 
At present, photoallergy testing is mainly conducted using animals, although some in vitro 
test as photoadduct formation and photooxidation can be useful screening tools. Among the 
different in vivo assay the modified LLNA assay or Photo-LLNA is preferred for the reduction 
in the number of animals required and the lessening of animal pain and distress due to the 
reduction of the amount of time. However, the 7th amendment to the cosmetics Directive 
(Directive 76/768/EEC) foresees a complete ban on animal testing for cosmetics ingredients 
from 2013 for all the human-health related effects. On the other hand, the implementation of 
REACH legislation urgently demands developing feasible and reliable in vitro methods  
 
In this sense, the objective of this study was to evaluate the suitability of IL-8 release on 
THP-1 cells as a method for the detection of chemicals with photosensitizing potential.  
 
Our approach is based on two facts; first, we have recently demonstrated the usefulness of 
IL-8 release on THP-1 as a method to discriminate between allergens and irritants (Mitjans 
et al., 2008; Mitjans et al., 2010) second, allergic photocontact dermatitis and allergic contact 
dermatitis presumably share the same mechanistic basis. 
 Light source is a crucial factor to study photosensitization being solar simulator lamps 
generally considered the optimal artificial light source. Nevertheless, other light sources can 
be considered if the wavelength range emission includes the absorption spectrum of the 
chemicals studied. In a recent workshop (Ceridono et al., 2012), it was underlined that the 
waveband concerned is mainly UVA, with some drugs extending to UVB and others to 
visible. Thus, we have chosen a pure UVA lamp source with an irradiance spectra ranging 
from 320 nm to 400 nm with a peak at 365 nm similarly to other studies (Galbiati et al., 
2013). The use of this irradiation source can underestimate the impact of some light visible 
photoreactive compounds. However, as the chemicals studied in this work, the majority of 
phototoxic compounds are predominantly UVA absorbers with significant higher clinical 
impact than other wavelength absorbers (Ceridono et al., 2012). Moreover, the information 
obtained with this photoassay will contribute to evaluation of photochemical characteristics 
using non clinical studies as an integrated process of photosafety assessment. 
 
The first step was to find the appropriate irradiation conditions. We tested several energy 
doses: 1.0, 2.5, and 5.0 J/cm2 with an intensity of 1.6-2.1 mW/cm2. The higher UVA dose 
tested, 5 J/cm2, produced a significant release of IL-8 in untreated cells, and the lowest, 1 
J/cm2, was not enough to produce a significant release of IL-8 in presence of chlorpromazine 
at sub-toxic concentrations. Therefore, the selected light dose in this study was 2.5 J/cm2 
which it did not affect cell viability nor produced a significant IL-8 release. In contrast, in the 
work of Hoya et al. (2009) where they proposed THP-1 and the expression of CD86 and 
CD54 to assess photoallergenicity, they selected a dose of 5.0 J/cm2 with an intensity of 1.7 
mW/cm2 as the appropriate test condition to detect the effects of photoallergens (Hoya 
2009). However, the dose of 2.5 J/cm2 with an intensity of 1.7 mW/cm2 (similar to our 
experimental conditions) was also enough to induce a dose-dependent induction of CD86 
and CD54 expression. These doses (2.5-5 J/cm2) are also used in photopatch testing in 
humans (Bruynzeel et al., 2004, Kerr et al., 2012).  
 
To discriminate photoallergens from photoirritants, we have selected seven known 
photoallergens, four are UV filters (BZP, AVO, PABA, and OMC), one nonsteroidal anti-
inflammatory drug (KETO), one antipsychotic drug (CPZ), and a fragrance (6-MC). Under 
the irradiation conditions, photoallergens induced a dose-response release of IL-8 (Figure 2). 
We also examined three compounds described as photoirritants using the same 
experimental conditions, ibuprofen (IBU) a nonsteroidal anti-inflammatory drug, retinoic acid 
(RET), a topical drug commonly used for treating acne, and 8-methoxypsoralen (8-MOP), a 
drug used for psoriasis. IBU and RET also produced a slight increase of IL-8 release 
statistically significant after irradiation. But when the overall SI was calculated for 
photoirritants, they did not reach a value above 2. We also included negative compounds, 
allergens and irritants. In the case of allergens (DEM, 2-AP, and NiSO4), we observed 
significant increases of IL-8 in non-irradiated cells (Figure 3), confirming previous results 
(Mitjans et al., 2008; Mitjans et al., 2010). The irritants (SDS and OCT) failed to stimulate IL-
8 release in irradiated and non-irradiated conditions.  
 
Among photoallergens, CPZ and AVO were the chemicals that produced the strongest 
reaction in terms of SI after irradiation above 10. In contrast, KETO and PABA were the less 
potent in our experimental conditions, although, the high incidence of photoallergic reactions 
reported in human photopatch studies (Diaz et al., 2006; Hindsen et al., 2004; Kerr et al., 
2012; Waters et al., 2009; Wennersten et al., 1984). However, it is true that the use of non 
standardized protocols could mislead the conclusions concerning the potential 
photoallergenicity of PABA and this product is an stronger absorber of UVB (SCCP/1008/06).  
 
OMC and AVO, two of the photoallergens tested in this study also showed strong responses 
in non irradiated conditions. It is not surprising that some photoallergens had some 
sensitization potential. In a recent multicentre study conducted in Europe using photopatch 
testing on patients with a history of dermatitis of photodermatitis, both compounds produced 
allergic contact dermatitis and photoallergic contact dermatitis reactions (Kerr et al., 2012). 
Although Hayden et al., (2005) demonstrated that AVO presents a low skin penetration, 
there exist some reports of positive photoallergic and allergic contact reactions in front this 
UV filter (Kerr and Ferguson 2010; Kerr et al., 2012) and it is included in the chemical panel 
for photopatch test assays (Ibbotson et al., 1997; Bruynzeel et al., 2004). In this sense, it has 
recently been shown that AVO photodegrades to benzyls and arylglyoxals. The latter 
compound is a strong skin sensitizer, and photocontact allergy to dibenzoylmethanes may 
therefore be due to the formation of arylgloxals in skin (Karlsson et al., 2009).  
 
When we analyzed the results of all the compounds, we found that six out of seven 
photoallergens reached an overall SI above 2.5. While the entire set of negative compounds 
(photoirritants, allergens, and irritants) had overall SI below 2.5. Therefore, we propose a 
tentative cut-off value of 2.5 in the overall SI to identify chemicals with photosensitizing 
potential. Based on these data, sensitivity and accuracy of the method was calculated 
obtaining 85.7% and 93.3%, respectively, with a positive predictivity of 100% and a negative 
predictivity of 88.8%.  
 
Although we need to further confirm the applicability of the test evaluating a wider battery of 
chemicals, we consider that this assay may become a useful cell-based in vitro test for 
evaluating the photosensitizing potential of chemicals. 
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Legend to figures 
Figure 1: Spectral power distribution of Actinic BL TL/TL-D/T5 lamp. Energy was measured 
at various distances from irradiation source. 
 
Figure 2. IL-8 release and cell viability induced by increasing amounts of UVA irradiation (0-5 
J/cm2) in untreated cells and cells treated with 0.5 µM of chlorpromazine. Results are 
presented as mean ± ES of 3 independent experiments. Statistical analysis was performed 
with Dunnett’s multiple comparison test (*p <0.05, **p <0.01). 
 
Figure 3. IL-8 release induced by increasing concentrations of the selected photoallergens 
(CPZ, 6-MC, BZP, KETO, AVO, PABA, OMC) and photoirritants (8-MOP, RET, IBU) in non-
irradiated (open circles) and irradiated cells (black squares). SI calculated for each 
concentration tested is also shown (black triangles).  Cell viability was found to be above the 
75% in all the concentrations tested as measured by the MTT assay. Results are presented 
as mean ± SE of at least 3 independent experiments, and statistical analysis was performed 
with Dunnett’s multiple comparison test (* p <0.05, **p <0.01).  
 
Figure 4. IL-8 release induced by increasing concentrations of the negative compounds 
(NiSO4, 2-AP, DEM, OCT, SDS) in non-irradiated (open circles) and irradiated cells (black 
squares).  SI calculated for each concentration tested is also shown (black triangles). Cell 
viability was found to be above the 75% in all the concentrations tested as measured by the 
MTT assay. Results are presented as mean ± SE of at least 3 independent experiments, and 
statistical analysis was performed with Dunnett’s multiple comparison test (* p <0.05, **p 
<0.01).  
 
Figure 5. The increases of IL-8 release are expressed as stimulation indexes for non-
irradiated (NI-SI) and irradiated cells (I-SI). An overall stimulation index (I-SI/NI-SI) was 
calculated as the ratio of the stimulation indexes in irradiated and non-irradiated cells. The 
concentrations assayed were: 0.63 µM (CPZ), 80 µM (6-MC), 50 µM (BZP), 62.5 µM 
(KETO), 100 µM (AVO), 7.5 mM (PABA), 500 µM (OMC), 25 µM (RET), 0.015 µM (8-MOP), 
1000 µM (IBU), 12.5 µM (2-AP), 100 µM (DEM), 5.0 mM (OCT), 125 µM (SDS), 500 µM 
(NiSO4).  
 
  
 
Table 1. Chemicals selected according to their classifications as photoirritants and/or 
photoallergens.  
Compound Category Reference 
Chlorpromazine Photoallergen/photoirritant Ibbotson et al., 1997; Lankerani and Baron, 2004; 
Hoya et al., 2009; Karschuk et al., 2010 
6-methylcoumarin Photoallergen Ibbotson et al., 1997; Lankerani and Baron, 2004; 
Hoya et al., 2009; Cardoso et al., 2009; Karschuk et 
al., 2010 
Benzophenone Photoallergen Lankerani and Baron, 2004; Hoya et al., 2009; Kerr 
and Ferguson, 2010; Kerr et al., 2012; 
Ketoprofen Photoallergen Lankerani and Baron, 2004; Hoya et al., 2009; Kerr 
and Ferguson, 2010; Kerr et al., 2012; 
Avobenzone Photoallergen Ibbotson et al., 1997; Kerr and Ferguson, 2010; 
Kerr et al., 2012 
4-aminobenzoic acid Photoallergen Ibbotson et al., 1997; Lankerani and Baron, 2004; 
SCCP, 2006; Water et al., 2009; Kerr and 
Ferguson, 2010; 
2-ethylhexyl-4-
methoxycinnamate 
Photoallergen Ibbotson et al., 2001; Kerr and Ferguson, 2010; 
Kerr et al., 2012; 
Retinoic acid Photoirritant Lankerani and Baron, 2004 
8-methoxypsoralen Photoirritant Lankerani and Baron, 2004 
Ibuprofen Photoirritant Lankerani and Baron, 2004 
2-aminophenol Allergen Mitjans et al., 2010 
Diethylmaleate Allergen Mitjans et al., 2010 
Nickel sulfate Allergen Mitjans et al., 2008; Karschuk et al., 2010  
Octanoic acid Irritant Robinson MK, 2002 
Sodium dodecyl 
sulfate 
Irritant Mitjans et al, 2008; Hoya et al., 2009 
 
Table 2. Concentration (µM) of the chemical that induced 75% viability (CV75) in non-
irradiated and irradiated conditions (2.5 J/cm2). 
Compound CV75 Non-Irradiated CV75 Irradiated 
Chlorpromazine 4.7 1.0 
6-methylcoumarin > 1000* 75.5 
Benzophenone 514.8 48.6 
Ketoprofen > 1000* 49.7 
Avobenzone > 200* 100,0 
4-aminobenzoic acid > 1000* > 1000* 
2-ethylhexyl-4-
methoxycinnamate 
652.7 500.0 
Retinoic acid 123.2 29.9 
8-methoxypsoralen 702.2 0.2 
Ibuprofen > 1000* > 1000* 
2-aminophenol >1000* 60.2 
Diethylmaleate 394.2 346.2 
Nickel sulfate 958.8 510.1 
Octanoic acid > 1000* > 1000* 
Sodium dodecyl sulfate 105.8 91.1 
1 x 10
6
/ml cells were treated with increasing concentration of the selected chemicals or vehicle control in both 
irradiated and non-irradiated conditions. Cell viability was assessed by MTT reduction as described in Materials 
and Methods section. CV75 was calculated by linear regression analysis of data of at least 3 independent 
experiments. *Maximal concentration assayed with no effects on cell viability. 
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Figure 1: Spectral power distribution of Actinic BL TL/TL-D/T5 lamp 
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Figure 3. IL-8 release induced by increasing concentrations of the selected photoallergens (CPZ, 6-MC, BZP, KETO, AVO, PABA and OMC) and photoirritants 
(8-MOP, RET  and IBU) in non-irradiated (open circles) and irradiated cells (black squares).  SI calculated for each concentration tested is also shown 
(black triangles). Cell viability was found to be above the 75% in all the concentrations tested as measured by the MTT assay. Results are presented as 
mean  SE of at least 3 independent experiments,  and statistical analysis was performed with Dunnett’s multiple comparison test (* p <0.05, **p <0.01).  
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Figure 4. IL-8 release induced by increasing concentrations of the negative compounds in non-
irradiated (open circles) and irradiated cells (black squares).  SI calculated for each concentration 
tested is also shown (black triangles). Cell viability was found to be above the 75% in all the 
concentrations tested as measured by the MTT assay. Results are presented as mean ± SE of at 
least 3 independent experiments,  and statistical analysis was performed with Dunnett’s multiple 
comparison test (* p <0.05, **p <0.01).  
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Figure 5. The increases of IL-8 release are expressed as stimulation indexes for non-irradiated (NI-SI) 
and irradiated cells (I-SI). An overall stimulation index (I-SI/NI-SI) was calculated as the ratio of the 
stimulation indexes in irradiated and non-irradiated cells. The concentrations assayed were: 0.63 µM 
(CPZ), 80 µM (6-MC), 50 µM (BZP), 62.5 µM (KETO), 100 µM (AVO), 7.5 mM (PABA), 500 µM (OMC), 25 
µM (RET), 0.015 µM (8-MOP), 1000 µM (IBU), 12.5 µM (2-AP), 100 µM (DEM), 5.0 mM (OCT), 125 µM 
(SDS), 500 µM (NiSO4).  
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Highlights 
No in vitro methods have been adopted to assess photosensitization 
We explore the use of IL-8 release by THP-1 cells to identify photosensitizers 
Photoallergens induced a dose-related increase of IL-8 after irradiation 
A tentative cut-off is proposed to discriminate photoallergens from photoirritants 
The assay may become a useful cell-based in vitro test to assess photosensitization 
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